News

Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.

Please consider a small donation if you think this website provides you with relevant information  

   
Date Title Source
2024-03-20 6:16:52 am Celularity Submits Request to U.S. FDA for Orphan Drug Designation for PDA-002 Asset Treating Facioscapulohumeral Muscular Dystrophy GlobeNewsWire
2024-03-14 6:15:0 am Celularity CEO to Present on Cell Therapy’s Potential to Improve Longevity at 2024 ABUNDANCE Summit GlobeNewswire
2024-03-12 6:20:0 am Celularity CEO to Present Keynote Address at 2024 Society for Brain Mapping and Therapeutics Annual World Congress GlobeNewswire
2024-03-07 6:35:0 am Celularity to Present Data Showing Cancer Tumor Reduction by Off-the-Shelf Cell Therapy Derived from Human Placental Cells GlobeNewswire
2024-02-23 1:10:0 pm Celularity Announces 1-for-10 Reverse Stock Split GlobeNewswire
2024-02-14 1:5:0 pm Celularity’s Tri-layer Decellularized, Dehydrated Human Amniotic Membrane Product Investigated as a Carrier of Induced Pluripotent Stem Cell Derived-Limbal Stem Cells in the Treatment of Severe Ocular Surface Disease GlobeNewswire
2024-02-01 6:0:0 am Celularity Announces Net Sales Expectations for First Quarter 2024 and Full Year 2024, Reiterates Advanced Biomaterial Product Commercial and Development Pipeline GlobeNewswire
2024-01-25 6:0:0 am Celularity and Genting Leaders Comments on Closing $21 Million Financing Transactions GlobeNewswire
2024-01-18 10:40:0 am Celularity Releases CEO Letter to Shareholders GlobeNewswire
   

Please consider a small donation if you think this website provides you with relevant information